PMFA
TTHI

Plante Moran Financial Advisors’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Plante Moran Financial Advisors’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-17,034
Closed -$25K – 1050
2016
Q2 		$25K Hold
17,034
– – 0.02% 402
2016
Q1 		$22K Hold
17,034
– – 0.02% 375
2015
Q4 		$33K Hold
17,034
– – 0.02% 375
2015
Q3 		$30K Hold
17,034
– – 0.02% 332
2015
Q2 		$36K Buy
17,034
+8,500
+100% +$59.6K 0.03% 344
2015
Q1 		$58K Hold
8,534
– – 0.04% 263
2014
Q4 		$58K Hold
8,534
– – 0.04% 262
2014
Q3 		$59K Hold
8,534
– – 0.05% 234
2014
Q2 		$57K Hold
8,534
– – 0.05% 218
2014
Q1 		$68K Hold
8,534
– – 0.07% 145
2013
Q4 		$49K Hold
8,534
– – 0.03% 247
2013
Q3 		$35K Hold
8,534
– – 0.02% 228
2013
Q2 		$28K Buy
+8,534
New +$24.2K 0.02% 220

Other funds holding TTHI

HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Plante Moran Financial Advisors's TTHI Position: Q3 2016 in Review

Plante Moran Financial Advisors sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 17,034 shares — an estimated $25K sold.

Plante Moran Financial Advisors first reported a position in TTHI in Q2 2013 and held it in 13 quarters. The position peaked at $68K in Q1 2014. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • Plante Moran Financial Advisors reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 17,034 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $25K.
  • Plante Moran Financial Advisors first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 13 quarters.
  • Plante Moran Financial Advisors's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $68K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2016, filed 3 Nov 2016.